These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1480560)

  • 21. Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands.
    Chilmonczyk Z; Bojarski AJ; Pilc A; Sylte I
    Int J Mol Sci; 2015 Aug; 16(8):18474-506. PubMed ID: 26262615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proserotoninergic agents and depression (author's transl)].
    Uzan A
    Encephale; 1982; 8(2):273-89. PubMed ID: 6286277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment.
    Lowther S; De Paermentier F; Crompton MR; Katona CL; Horton RW
    Brain Res; 1994 Apr; 642(1-2):281-9. PubMed ID: 8032889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.
    Price LH; Charney DS; Delgado PL; Goodman WK; Krystal JH; Woods SW; Heninger GR
    J Clin Psychiatry; 1990 Apr; 51 Suppl():44-50; discussion 51-2. PubMed ID: 2182616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Density of guanine nucleotide-binding proteins in platelets of patients with major depression: increased abundance of the G alpha i2 subunit and down-regulation by antidepressant drug treatment.
    García-Sevilla JA; Walzer C; Busquets X; Escribá PV; Balant L; Guimón J
    Biol Psychiatry; 1997 Oct; 42(8):704-12. PubMed ID: 9325564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute tryptophan depletion: a method of studying antidepressant action.
    Miller HL; Delgado PL; Salomon RM; Licinio J; Barr LC; Charney DS
    J Clin Psychiatry; 1992 Oct; 53 Suppl():28-35. PubMed ID: 1429482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do G proteins have a role in antidepressant actions?
    Bourin M; Baker GB
    Eur Neuropsychopharmacol; 1996 Mar; 6(1):49-53. PubMed ID: 8866938
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotonergic gene expression and depression: implications for developing novel antidepressants.
    Lesch KP
    J Affect Disord; 2001 Jan; 62(1-2):57-76. PubMed ID: 11172874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT2A and 5-HT2C receptors and their atypical regulation properties.
    Van Oekelen D; Luyten WH; Leysen JE
    Life Sci; 2003 Apr; 72(22):2429-49. PubMed ID: 12650852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
    Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H; Schlake HP; Rolf LH; Rudolf GA
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
    Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
    Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Delay in the effect of antidepressive agents: pharmacologic approach].
    Allain H; Masson AV; Bentue-Ferrer D; Toulouse P; Lecoz F
    Encephale; 1995 Mar; 21 Spec No 2():9-15. PubMed ID: 7588184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death.
    Dowlatshahi D; MacQueen GM; Wang JF; Reiach JS; Young LT
    J Neurochem; 1999 Sep; 73(3):1121-6. PubMed ID: 10461903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed biochemical changes following antidepressant treatment.
    Sugrue MF
    Psychopharmacol Bull; 1985; 21(3):619-22. PubMed ID: 2994163
    [No Abstract]   [Full Text] [Related]  

  • 37. The marketing of 5-hydroxytryptamine: depression or anxiety?
    Healy D
    Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
    [No Abstract]   [Full Text] [Related]  

  • 38. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Status of amine hypotheses in depressive disorders].
    Fritze J; Deckert J; Lanczik M; Strik W; Struck M; Wodarz N
    Nervenarzt; 1992 Jan; 63(1):3-13. PubMed ID: 1314964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease rat model.
    Zhang QJ; Du CX; Tan HH; Zhang L; Li LB; Zhang J; Niu XL; Liu J
    Neuroscience; 2015 Dec; 311():45-55. PubMed ID: 26470809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.